Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 6/20 | 0.48 |
| ▸ | PLA2G4A | P47712 | 6/20 | 0.48 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17944992 | 0.98 | PLA2G2A (0.45) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17944114 | 0.97 | PLA2G2A (0.51) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17945596 | 0.94 | PLA2G2A (0.50) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17932103 | 0.94 | PLA2G2A (0.50) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL24518913 | 0.93 | HPGD (0.44) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17944558 | 0.92 | PLA2G2A (0.43) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17932162 | 0.91 | PLA2G2A (0.43) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL17944489 | 0.91 | PLA2G2A (0.47) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL23502100 | 0.91 | PLA2G2A (0.43) | PLA2G2APLA2G4APLA2G10CA1CA2 | |
| SCHEMBL24983047 | 0.91 | PLA2G2A (0.47) | PLA2G2APLA2G4APLA2G10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024136070-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024096410-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2024-05-10 | — | — | WO | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230329025-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-4245743-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | Lg Chem, Ltd. (KR) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023172110-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-09-14 | — | — | WO | disclosed |
| EP-4242196-A1 | METHOD FOR PREPARING DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND AND COMPOSITION | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022169218-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | 주식회사 엘지화학 | 2022-08-11 | — | — | WO | disclosed |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-20160218297-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-20160218297-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, OR51E2, LOXL1 | PLA2G2A 2426/4885PLA2G4A 3720/4885PLA2G10 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.